144 related articles for article (PubMed ID: 15475002)
1. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Li Y; Lu C; Xing G; Zhu Y; He F
Exp Cell Res; 2004 Nov; 300(2):379-87. PubMed ID: 15475002
[TBL] [Abstract][Full Text] [Related]
2. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
[TBL] [Abstract][Full Text] [Related]
3. Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway.
Lu C; Li Y; Zhao Y; Xing G; Tang F; Wang Q; Sun Y; Wei H; Yang X; Wu C; Chen J; Guan KL; Zhang C; Chen H; He F
FASEB J; 2002 Jan; 16(1):90-2. PubMed ID: 11709497
[TBL] [Abstract][Full Text] [Related]
4. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
6. Hepatopoietin interacts directly with COP9 signalosome and regulates AP-1 activity.
Wang Y; Lu C; Wei H; Wang N; Chen X; Zhang L; Zhai Y; Zhu Y; Lu Y; He F
FEBS Lett; 2004 Aug; 572(1-3):85-91. PubMed ID: 15304329
[TBL] [Abstract][Full Text] [Related]
7. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
9. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB.
Li Y; Liu W; Xing G; Tian C; Zhu Y; He F
Cell Signal; 2005 Aug; 17(8):985-96. PubMed ID: 15894171
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
[TBL] [Abstract][Full Text] [Related]
11. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor interacts with HBx and inhibits its apoptotic activity.
Zhang S; Lin R; Zhou Z; Wen S; Lin L; Chen S; Shan Y; Cong Y; Wang S
Biochem Biophys Res Commun; 2006 Apr; 342(2):671-9. PubMed ID: 16488392
[TBL] [Abstract][Full Text] [Related]
13. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
[TBL] [Abstract][Full Text] [Related]
14. Psoriasin interacts with Jab1 and influences breast cancer progression.
Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
[TBL] [Abstract][Full Text] [Related]
15. Hepatopoietin acts as an autocrine growth factor in hepatoma cells.
Li Y; Xing G; Wang Q; Li M; Wei H; Fan G; Chen J; Yang X; Wu C; Chen H; He F
DNA Cell Biol; 2001 Dec; 20(12):791-5. PubMed ID: 11879572
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth through introduction of an antisense plasmid of macrophage migration inhibitory factor.
Sasaki Y; Kasuya K; Nishihira J; Magami Y; Tsuchida A; Aoki T; Koyanagi Y
Int J Mol Med; 2002 Nov; 10(5):579-83. PubMed ID: 12373295
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Hira E; Ono T; Dhar DK; El-Assal ON; Hishikawa Y; Yamanoi A; Nagasue N
Cancer; 2005 Feb; 103(3):588-98. PubMed ID: 15612021
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer.
Chen YC; Zhang XW; Niu XH; Xin DQ; Zhao WP; Na YQ; Mao ZB
Oncogene; 2010 May; 29(21):3067-78. PubMed ID: 20383199
[TBL] [Abstract][Full Text] [Related]
19. [Isolation and characterization of a novel transcript of hepatopoietin].
Lü J; Xu WX; Zhan YQ; Cui XL; Cai WM; He FC; Yang XM
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):225-30. PubMed ID: 12007001
[TBL] [Abstract][Full Text] [Related]
20. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
Shimizu T; Abe R; Nakamura H; Ohkawara A; Suzuki M; Nishihira J
Biochem Biophys Res Commun; 1999 Nov; 264(3):751-8. PubMed ID: 10544003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
